Page last updated: 2024-08-24

fluorodeoxyglucose f18 and tak-901

fluorodeoxyglucose f18 has been researched along with tak-901 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Binns, D; Bogatyreva, E; Bradley, DP; Cullinane, C; de Jong, R; Hicks, RJ; McArthur, GA; Waldeck, KL	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and tak-901

Article	Year
Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901. Nuclear medicine and biology, 2014, Volume: 41, Issue:2 Topics: Animals; Aurora Kinase B; Biological Transport; Biomarkers, Tumor; Carbolines; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Sulfones; Treatment Outcome	2014

Article

Year

Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.

Nuclear medicine and biology, 2014, Volume: 41, Issue:2

Topics: Animals; Aurora Kinase B; Biological Transport; Biomarkers, Tumor; Carbolines; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Sulfones; Treatment Outcome

2014